Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 11: | Line 11: | ||
=====[[Dihydrofolate reductase|Dihydrofolate Reductase]] Inhibitor===== | =====[[Dihydrofolate reductase|Dihydrofolate Reductase]] Inhibitor===== | ||
* Alimta - Generic: Pemetrexed | * Alimta - Generic: Pemetrexed | ||
| + | * Folotyn - Generic: Pralatrexate | ||
* [[Methotrexate]] | * [[Methotrexate]] | ||
| + | * Raltitrexed | ||
=====[[Epidermal Growth Factor Receptor]] Inhibitor===== | =====[[Epidermal Growth Factor Receptor]] Inhibitor===== | ||
* [[Herceptin]] - Generic: Trastuzumab | * [[Herceptin]] - Generic: Trastuzumab | ||
Revision as of 00:04, 18 November 2011
Anti-CD20 Monoclonal AntibodyB-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
